Asia Pacific Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)

TIPRE00027821 | Pages: 144 | Biotechnology | Mar 2022 | Type: Regional | Status: Published

Market Introduction

Asia Pacific genome editing market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is expected to be the fastest-growing region among all other regions. The growth of the market in Asia Pacific is expected to grow at a faster pace owing to factors such as the increasing need for superior treatment solutions and increasing focus on research and development activities. Additionally, developing healthcare infrastructure and increasing investments in order to boost the research activities are projected to drive the Asia Pacific genome editing market during the forecast period.

In January 2020, after a series of cases of pneumonia in Wuhan, the Chinese health authorities, the capital city of Hubei province (China), announced that a novel coronavirus, officially known as severe acute respiratory syndrome coronavirus (SARS-CoV)-2, was responsible for these cases. COVID-19 has created an extraordinary emergency that is particularly affecting the supply chain. The supply chain disruptions, along with the enormous demand for effective therapies for the treatment of COVID 19 have put the healthcare research industry in a critical situation in the Asia Pacific region. However, many of the market players now realized the importance of gene therapy in the treatment of COVID 19 which is expected to raise demand for genome editing during the forecast period.


Get more information on this report :



Market Overview and Dynamics

The genome editing market in Asia Pacific is expected to grow US$ 1,051.58 million in 2021 to US$ 3,557.63 million by 2028; it is estimated to grow at a CAGR of 19.0% from 2021 to 2028. According to the World Health Organization (WHO), cancer is the biggest cause of death in the region. Overall, the burden of cancer incidence and death is quickly increasing, reflecting both population aging and growth, as well as changes in the prevalence and distribution of the key cancer risk factors, many of which are related to socio-economic development. CANCER TODAY enabled a comprehensive assessment of the cancer burden. In 2020, based on the GLOBOCAN estimates of incidence, mortality, and prevalence for 2020 in 185 countries or territories for 36 cancer types by sex and age group. According to the recent estimates, the incidence of cancer has been increasing at an alarming rate, making hepatocellular carcinoma (HCC the fifth most common cancer in men and the seventh most common cancer in women. HCC is likely to contribute to ~5.6% of all human cancers, thereby increasing the burden in 2020. The HCC is known to be the second leading cause of cancer-related deaths worldwide. Almost 85% of HCCs occur in developing countries. Other types of liver cancers are cholangiocellular carcinoma (CCC), a malignant disease of the liver bile ducts, and hepatoblastoma. Hepatoblastoma is the most common malignant tumor of the liver in children. Thus, a rise in the prevalence of liver diseases, including chronic and acute diseases and microbial infections, increases the demand for liver models. A chromosomal abnormality can be detected in about one out of every 150 live births. Yet even this high incidence represents only a small fraction of chromosome mutations since the vast majority are lethal and result in prenatal death or stillbirth. Indeed, 50% of all first-trimester miscarriages and 20% of all second-trimester miscarriages are estimated to involve a chromosomally abnormal fetus. Although Down syndrome is the most well-known and well-recognized autosomal trisomies, it is only diagnosed in around one out of every 800 live births. Many cancer biology investigations are now using CRISPR as a standard approach. The CRISPR/Cas9 system has been shown to be effective in treating metastatic tumors, which is a big step toward discovering a cancer cure. The CRISPR-LNPs system contains a messenger RNA that encodes for the Cas9 CRISPR enzyme, which operates as molecular scissors to cut the DNA of cells. CRISPR-based studies have opened new doors to treating hereditary or developmental neurological disorders (HNDs) such as fragile X syndrome and Down syndrome. Thus, the increasing factors of genome editing are expected to boost the growth of the genome editing market during the forecast period.

Key Market Segments

In term of technological, CRISPR segment held a larger market share of the genome editing market in 2021. In term of application, genetic engineering segment held a larger market share of the genome editing market in 2021. In term of end user, pharmaceutical and biotechnology companies segment held a larger market share of the genome editing market in 2021.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the genome editing market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are THERMO FISHER SCIENTIFIC INC.; MERCK KGaA; Lonza; Horizon Discovery Group plc.; Integrated DNA Technologies; GenScript; New England Biolabs; Eurofins Scientific; and CRISPR Therapeutics among others.

Reasons to buy report

  • To understand the Asia Pacific genome editing market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific genome editing market
  • Efficiently plan M&A and partnership deals in Asia Pacific genome editing market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific genome editing market
  • Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.

Asia Pacific Genome Editing Market Segmentation

Asia Pacific Genome Editing Market – By Technology

  • CRISPR
  • TALEN
  • Antisense
  • Other

Asia Pacific Genome Editing Market – By Application

  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostic Applications
  • Drug Discovery
  • Others

Asia Pacific Genome Editing Market – By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Clinical Research Organizations (CRO's)

Asia Pacific Genome Editing Market – By Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

Asia Pacific Genome Editing Market – Companies Mentioned

  • THERMO FISHER SCIENTIFIC INC.
  • MERCK KGaA
  • Lonza
  • Horizon Discovery Group plc.            
  • Integrated DNA Technologies         
  • GenScript
  • New England Biolabs
  • Eurofins Scientific
  • CRISPR Therapeutics

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Genome Editing Market– By Technology

1.3.2        Asia Pacific Genome Editing Market– By Application

1.3.3        Asia Pacific Genome Editing Market– By End User

1.3.4        Asia Pacific Genome Editing Market– By Country

2.           Asia Pacific Genome Editing Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Genome Editing Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinion

5.           Asia Pacific Genome Editing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Prevalence of Cancer and Other Genetic Disorders

5.1.2        Continual Technological Advancements in Gene-Editing Tools

5.2         Market Restraints

5.2.1        Heavy Cost of Genomic Equipment

5.3         Market Opportunities

5.3.1        Prospering Biotechnology Industry in Emerging Regions

5.4         Future Trends

5.4.1        Increasing Technological Innovations

5.5         Impact Analysis

6.           Asia Pacific Genome Editing Market Analysis

6.1         Asia Pacific Genome Editing Market Revenue Forecast and Analysis

7.           Asia Pacific Genome Editing Market Revenue and Forecasts to 2028– by Technology

7.1         Overview

7.2         Asia Pacific Genome Editing Market, By Technology, 2021 & 2028 (%)

7.3         Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

7.3.1        Overview

7.3.2        CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.4         TALEN

7.4.1        Overview

7.4.2        TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.5         Antisense

7.5.1        Overview

7.5.2        Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Genome Editing Market Revenue and Forecasts to 2028 – Application

8.1         Overview

8.2         Asia Pacific Genome Editing Market Share, By Application - 2021 & 2028 (%)

8.3         Cell Line Engineering

8.3.1        Overview

8.3.2        Cell Line Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.4         Genetic Engineering

8.4.1        Overview

8.4.2        Genetic Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.5         Diagnostic Applications

8.5.1        Overview

8.5.2        Diagnostic Applications: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.6         Drug Discovery

8.6.1        Overview

8.6.2        Drug Discovery: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Genome Editing Market Revenue and Forecasts to 2028 – End User

9.1         Overview

9.2         Asia Pacific Genome Editing Market Share by End User - 2021 & 2028 (%)

9.3         Pharmaceutical and Biotechnology Companies

9.3.1        Overview

9.3.2        Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.4         Clinical Research Organizations (CRO’s)

9.4.1        Overview

9.4.2        Clinical Research Organizations: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.5         Academic and Research Institutes

9.5.1        Overview

9.5.2        Academic and Research Institutes: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Genome Editing Market Revenue and Forecasts to 2028 – Country Analysis

10.1      Overview

10.1.1     Asia Pacific: Genome Editing Market, by Country, 2021 & 2028 (%)

10.1.1.1       China: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       China: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       China: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4       China: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.5       China: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       Japan: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Japan: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Japan: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       Japan: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.5       Japan: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       India: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       India: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       India: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       India: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5       India: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.6       South Korea: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.7       Overview

10.1.1.3.8       South Korea: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.9       South Korea: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.10    South Korea: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.11    South Korea: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.1.1.4       Australia: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       Australia: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.5       Australia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Australia: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.2       Australia: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.1.1.6       Rest of Asia Pacific: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Asia Pacific: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3       Rest of Asia Pacific: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4       Rest of Asia Pacific: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5       Rest of Asia Pacific: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Asia Pacific Genome Editing Market

11.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.        Asia Pacific Genome Editing Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      THERMO FISHER SCIENTIFIC INC.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      MERCK KGaA

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Lonza

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Horizon Discovery Group plc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Integrated DNA Technologies

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      GenScript

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      New England Biolabs

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Eurofins Scientific

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      CRISPR Therapeutics

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      Glossary of Terms

 


LIST OF TABLES

Table 1.             China: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2.             China: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3.             China: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Japan: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Japan: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Japan: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             India: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 8.             India: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9.             India: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10.          South Korea: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 11.          South Korea: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12.          South Korea: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Australia: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Australia: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Australia: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest of Asia Pacific: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of Asia Pacific: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of Asia Pacific: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Organic Developments Done by Companies

Table 20.          Inorganic Developments Done by Companies

Table 21.          Glossary of Terms, Asia Pacific Genome Editing Market

 


LIST OF FIGURES

Figure 1.           Asia Pacific Genome Editing Market Segmentation

Figure 2.           Asia Pacific Genome Editing Market Segmentation, By Country

Figure 3.           Asia Pacific Genome Editing Market Overview

Figure 4.           CRISPR Held Largest Share of Technology Segment in Asia Pacific Genome Editing Market

Figure 5.           China to Show Remarkable Growth During Forecast Period

Figure 6.           Asia Pacific Genome Editing Market, Industry Landscape

Figure 7.           Asia Pacific: PEST Analysis

Figure 8.           Expert Opinion

Figure 9.           Asia Pacific Genome Editing Market Impact Analysis of Drivers and Restraints

Figure 10.        Asia Pacific Genome Editing Market– Revenue Forecast and Analysis – 2021-2028

Figure 11.        Asia Pacific Genome Editing Market, by Technology, 2021 & 2028 (%)

Figure 12.        CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Asia Pacific Genome Editing Market Share, by Application - 2021 & 2028 (%)

Figure 17.        Cell Line Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Genetic Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Diagnostic Applications: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        Drug Discovery: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Others: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Asia Pacific Genome Editing Market Share by End User - 2021 & 2028 (%)

Figure 23.        Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Clinical Research Organizations: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Academic and Research Institutes: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        Asia Pacific: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)

Figure 27.        Asia Pacific: Genome Editing Market, by Country, 2021 & 2028 (%)

Figure 28.        China: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Japan: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30.        India: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        South Korea: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Australia: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Rest of Asia Pacific: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

  1. THERMO FISHER SCIENTIFIC INC.
  2. MERCK KGaA
  3. Lonza
  4. Horizon Discovery Group plc.            
  5. Integrated DNA Technologies         
  6. GenScript
  7. New England Biolabs
  8. Eurofins Scientific
  9. CRISPR Therapeutics
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific genome editing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific genome editing market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the genome editing market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000